GUIDED THERAPEUTICS, INC. (GTHP)

0.23 -1.28% (-0.00)

Over 5Y: -54.4%

2026-08-28
0.2 0.4 0.6 0.8
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '21 — Revenue: 19K Q3 '21 — Operating Cash Flow: -739K Q3 '21 — Free Cash Flow: -744K Q3 '21 — Net Income: 68K Q4 '21 — Revenue: 60K Q4 '21 — Operating Cash Flow: 159K Q4 '21 — Free Cash Flow: 155K Q4 '21 — Net Income: -444K Q1 '22 — Revenue: 5K Q1 '22 — Operating Cash Flow: -179K Q1 '22 — Free Cash Flow: -193K Q1 '22 — Net Income: -507K Q2 '22 — Revenue: 5K Q2 '22 — Operating Cash Flow: -349K Q2 '22 — Free Cash Flow: -366K Q2 '22 — Net Income: -926K Q3 '22 — Revenue: 3K Q3 '22 — Operating Cash Flow: -612K Q3 '22 — Free Cash Flow: -615K Q3 '22 — Net Income: -1.1M Q4 '22 — Revenue: 0 Q4 '22 — Operating Cash Flow: -339K Q4 '22 — Free Cash Flow: -342K Q4 '22 — Net Income: -1.8M Q1 '23 — Revenue: 22K Q1 '23 — Operating Cash Flow: -499K Q1 '23 — Free Cash Flow: -499K Q1 '23 — Net Income: -869K Q2 '23 — Revenue: 44K Q2 '23 — Operating Cash Flow: -438K Q2 '23 — Free Cash Flow: -438K Q2 '23 — Net Income: -1.6M Q3 '23 — Revenue: 0 Q3 '23 — Operating Cash Flow: -473K Q3 '23 — Free Cash Flow: -473K Q3 '23 — Net Income: -677K Q4 '23 — Revenue: 32K Q4 '23 — Operating Cash Flow: -336K Q4 '23 — Free Cash Flow: -336K Q4 '23 — Net Income: -386K Q1 '24 — Revenue: 6K Q1 '24 — Operating Cash Flow: -100K Q1 '24 — Net Income: -402 Q2 '24 — Revenue: 0 Q2 '24 — Operating Cash Flow: -214K Q2 '24 — Net Income: -709K Q3 '24 — Revenue: 0 Q3 '24 — Operating Cash Flow: -473K Q3 '24 — Net Income: -654K Q4 '24 — Revenue: 1K Q4 '24 — Operating Cash Flow: -332K Q4 '24 — Free Cash Flow: -332K Q4 '24 — Net Income: -652K Q1 '25 — Revenue: 0 Q1 '25 — Operating Cash Flow: -331K Q1 '25 — Net Income: -427K Q2 '25 — Revenue: 117K Q2 '25 — Operating Cash Flow: -169K Q2 '25 — Net Income: -811K Q3 '25 — Revenue: 60K Q3 '25 — Operating Cash Flow: -277K Q3 '25 — Net Income: -742K Q4 '25 — Revenue: 590K Q4 '25 — Operating Cash Flow: -291K Q4 '25 — Free Cash Flow: -291K Q4 '25 — Net Income: -1.2M Q1 '26 — Revenue: 0 Q1 '26 — Operating Cash Flow: -617K Q1 '26 — Net Income: -500K Q2 '26 — Revenue: 0 Q2 '26 — Operating Cash Flow: -319K Q2 '26 — Net Income: -605K -1.5M -1M -500K 0 500K 1M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.2
SBC / sales 19.4%
OE margin -251.1%
Oper. margin -303.8%
Accruals -130.6%
Gross margin 75.8%
EBITDA margin -302.5%
FCF margin -231.7%
OCF margin -231.4%
Profit margin -471.5%
ROA -256.5%
OCF / EBIT —
ROCE —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.0
RPO / sales 0.29×
RPO growth -74.7%
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.2
ND/EBITDA —
Current ratio 0.088×
Cash / Debt 0.23×
F-score 3.4 pts
Quick ratio 0.0044×
Cash runway —
Debt / Eq —
Debt payback —
Equity / Assets —
Net debt / Eq —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

9.9
Sales/sh Y/Y +302.7%
Sales CAGR 4Y +75.4%
Gross profit Y/Y +28450.0%
Sales Q/Q -100.0%
Shares change +36.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.